In-depth: The Treatment Era: ART in Africa

BOTSWANA: Model treatment programme has its problems

JOHANNESBURG, 6 December 2004 (IRIN In-Depth) - When the Botswana government decided to provide free antiretroviral (ARV) treatment to its HIV-positive citizens, the country was hailed for taking such a bold step at a time when some of its neighbours continued to debate the toxicity of the drugs and wrestle with how they would fund their treatment plans.

Two years on, while most countries in Southern Africa have embarked on some form of treatment programme, Botswana has about 35,000 people in the public and private sector receiving the life-prolonging drugs, funded by the Bill and Melinda Gates Foundation and the Merck Company Foundation.

But despite the progress in rolling out the programme, health and government officials are concerned that people still wait until they are very ill before seeking help, making it more difficult and expensive to treat them.

On average, HIV-positive Batswana access treatment when their CD4 count is at 80, according to Dr Ernest Darkoh, operations manager for the national ARV programme. Without HIV infection, the normal CD4 count range is 500-1,500. At 200 and below, a patient is at serious risk and treatment should begin.

At Princess Marina hospital in the capital, Gaborone, the Infectious Disease Care Clinic lies tucked behind the main hospital buildings. With about 12,000 people enrolled, this is one of the biggest treatment sites in the world.

Healthcare workers at the Princess Marina site see over 200 patients a day, many of who are "coming in sick beyond recovery". This has meant that the initiation process, which should take a couple of months to train patients and get them ready to begin taking the drugs, has had to be fast-tracked, Virginia Kebinakgabo, the clinic's sister-in-charge told PlusNews.

The workload can be attributed to fear of stigma and discrimination. Many of the patients travel long distances to get here, preferring the relative anonymity of the facility.

A patient who had travelled 50 km from Molepolole told PlusNews, "That's my home, I don't want them to see me queuing for ARVs."

Consequently, the pharmacy has had to make allowances for patients from outlying villages, who do not always come for their monthly supply of drugs on the scheduled dates.

Botswana has all the ingredients for turning the epidemic around: political leadership, optimal use of existing resources, and an established treatment plan. But fear of stigma has proved to be an even bigger hurdle.

"People are not yet free to talk about the epidemic. If they can't talk about it, then it will be even harder for them to get help," said Chris Molomo, head of the National AIDS Council.

The size of the population also plays a role - in a country of 1.7 million people, only a handful of individuals have gone public about their status.

ROUTINE TESTING AS A NEW STRATEGY

In January this year, the government introduced a policy of routine testing for HIV as part of its strategy for reducing stigma. Healthcare workers now offer HIV tests in public hospitals and clinics, but patients still have the right to refuse.

The change in strategy has been driven by the growing realisation that national plans to provide anti-AIDS medication were likely to fail unless more people knew their status.

"It's time to be much more aggressive and normalise it [HIV/AIDS] like any other condition. In a country where almost 40 percent of the population is [estimated to be] HIV positive, and there is therapy available, not offering an HIV test is tantamount to malpractice," Darkoh commented.

Both Darkoh and Molomo noted that with most clinics now testing about 90 percent of their patients, routine testing had significantly increased the number of people knowing their HIV status.

But human rights activists are concerned that the policy could erode the right of patients to withhold their consent, and that without full knowledge of the procedure and its potential impact, they could be coerced.

"The patient is not in charge. This policy does not treat people as right-bearers who can make their own decisions. It's highly unlikely that a patient will be able to tell a doctor that they want to opt out when they want to," Christine Stegling, coordinator of the Botswana Network on Ethics, Law and HIV/AIDS (BONELA), pointed out.

According to Stegling, the policy was still a political decision "without any technical backup" and it remained unclear how health facilities were implementing it. The public remained largely uninformed about routine testing and some clinics still did not have access to rapid testing kits.

"They are not addressing anything except their technical difficulty of late entry [in the ARV programme] - even then, I'm not sure how this policy is helping," she added.

What the government should be addressing is the fact that the country was missing a legislative framework that would make people comfortable with their HIV status, Stegling said. For example, Botswana does not have any policy on HIV/AIDS discrimination in the workplace.

Healthcare workers were another problem, she noted, as they projected "their own fears about HIV/AIDS onto the patients".

For Stegling, the bottom line is that "at the end of the day, people are scared to get tested, regardless of ARVs".

BONELA will soon be conducting research into whether people who had tested HIV-positive subsequently enrolled in the national ARV initiative. Until now, this had been very difficult to measure, Darkoh admitted.

The Treatment Era ART in Africa December 2004 C O N T E N T S Lead Features The Treatment Era Overview - Focus on Mozambique PDF file  Download this in-depth report 2.3 MB Delivery AFRICA: Show us the money! AFRICA: Healthcare workers feel impact of HIV BOTSWANA: Model treatment programme has its problems DJIBOUTI: Grappling with the demand for ARVs LESOTHO: Not enough staff, poor infrastructure, but ART launched NIGERIA: Restocked rollout expanded SOUTH AFRICA: Lusikisiki - a new model for ARV delivery SOUTH AFRICA: Rollout bogs down UGANDA: PLWAs at the centre of AIDS response Access AFRICA: Treatment criteria - deciding who gets to live MOZAMBIQUE: People living with AIDS overlooked in response SENEGAL: Free ARVs not enough to ensure access SOUTH AFRICA: Poverty, stigma and ignorance blights ART SOUTH AFRICA: The two sides of workplace HIV/AIDS treatment programmes SOUTH AFRICA: Monitoring access to free ARVs ZAMBIA: Second-class women left behind in access queue Treatment AFRICA: A short history of antiretrovirals AFRICA: Local manufacture - competition key to cheaper ARVs AFRICA: "Positive living" eclipsed by ARV drive AFRICA: MSF calls for child-friendly ARVs SOUTH AFRICA: HIV-positive and pregnant - weighing the risk Interviews AFRICA: Interview with Stephen Lewis, UN Special Envoy for HIV/AIDS in Africa AFRICA: Interview with Dr Jim Kim, director of WHO's HIV/AIDS department SOUTH AFRICA: Interview with treatment campaigner, Zackie Achmat ZAMBIA: Interview with Minister of Health Dr Brian Chituwo Links & References The WHO 3 by 5 Initiative www.who.int The Global Fund to Fight HIV/AIDS Tuberculosis and Malaria www.theglobalfund.org The President's Emergency Plan for AIDS Relief www.usaid.gov World Bank AIDS site www1.worldbank.org Pan-African Treatment Access Movement www.patam.org WHO Prequalification Project http://mednet3.who.int/ Eldis Resource on ARVs www.eldis.org In-Depth Feedback PlusNews welcomes feedback. Send your messages to feedback.

Feedback  |  Terms & Conditions  |  News Feeds  |  About PlusNews  |  Jobs  |  Donors

Copyright © IRIN 2011. All rights reserved. This material comes to you via IRIN, the humanitarian news and analysis service of the UN Office for the Coordination of Humanitarian Affairs. The opinions expressed do not necessarily reflect those of the United Nations or its Member States. The boundaries, names and designations used on maps on this site and links to external sites do not imply official endorsement or acceptance by the UN. Republication is subject to terms and conditions as set out in the IRIN copyright page.